Evidence map›Paper›PMID 36250733›Full record

ArticleActa dermato-venereologica2022

Longitudinal Evaluation of Biomarkers in Wound Fluids from Venous Leg Ulcers and Split-thickness Skin Graft Donor Site Wounds Treated with a Protease-modulating Wound Dressing.

Jacek Mikosiński, Konstantinos Kalogeropoulos, Louise Bundgaard, Cathrine Agnete Larsen, Simonas Savickas, Aleksander Moldt Haack, Konrad Pańczak, Katarzyna Rybołowicz, Tomasz Grzela, Michał Olszewski and 11 more

Open access · goldAbstract read
In one paragraph

Article in Acta dermato-venereologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 3 countries.

Jacek Mikosiński"MIKOMED", Clinic for Peripheral Vascular Diseases, 51/53 Pługowa Str., 94-238 Łódź, Poland.
Konstantinos KalogeropoulosDTU Bioengineering, Section for Protein Science and Biotherapeutics, Technical University of Denmark, Kgs. Lyngby, Denmark.
Louise BundgaardDTU Bioengineering, Section for Protein Science and Biotherapeutics, Technical University of Denmark, Kgs. Lyngby, Denmark; Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark.
Cathrine Agnete LarsenDTU Bioengineering, Section for Protein Science and Biotherapeutics, Technical University of Denmark, Kgs. Lyngby, Denmark.
Simonas SavickasDTU Bioengineering, Section for Protein Science and Biotherapeutics, Technical University of Denmark, Kgs. Lyngby, Denmark.
Aleksander Moldt HaackDTU Bioengineering, Section for Protein Science and Biotherapeutics, Technical University of Denmark, Kgs. Lyngby, Denmark.
Konrad PańczakECRAN - WOUND CARE CENTRE, Wrocław, Poland.
Katarzyna RybołowiczProfessional Treatment and Research Centre, Zbigniew Żęgota, 3C/44 Jana III Sobieskiego Str., 14-100 Ostróda, Poland.
Tomasz GrzelaClinic of Phlebology, Warsaw, Poland; Medical University of Warsaw, Warsaw, Poland.
Michał OlszewskiPratia Ostrołęka Embedded Hospital Clinical Research Site, Ostrołęka, Poland.
Piotr CiszewskiWILMED Specialist Medical Clinic Non-public Healthcare Centre, Warszaw, Poland.
Karina Sitek-ZiółkowskaSILMEDIC Medical Centre Sp. z o.o., Katowice, Poland.
Krystyna Twardowska-SauchaSpecialised Medical Centre "Medservice", Zabrze, Poland.
Marek KarczewskiCSOLUMED Medical Centre, Poznan, Poland; Poland Department of General and Transplant Surgery, Poznan University of Medical Sciences, Poznan, Poland.
Daniel RabczenkoInstytut Edukacji i.e. sp.z o.o., Warzawa, Poland.
Agnieszka SegietInstytut Edukacji i.e. sp.z o.o., Warzawa, Poland.
Patrycja Buczak-KulaClinMed Pharma, Warzawa, Poland.
Erwin M SchoofDTU Bioengineering, Section for Protein Science and Biotherapeutics, Technical University of Denmark, Kgs. Lyngby, Denmark.
Sabine A EmingDepartment of Dermatology, University of Cologne, Cologne, Germany.
Hans SmolaDepartment of Dermatology, University of Cologne, Cologne, Germany; PAUL HARTMANN AG, Heidenheim, Germany. hans.smola@hartmann.info.
Ulrich Auf dem KellerDTU Bioengineering, Section for Protein Science and Biotherapeutics, Technical University of Denmark, Kgs. Lyngby, Denmark. uadk@dtu.dk.
Technical University of Denmark · DKHartmann Group (Germany) · DEKardio-Med Silesia · PLMedical University of Warsaw · PLPoznan University of Medical Sciences · PLUniversity of Cologne · DEUniversity of Copenhagen · DKWroclaw Research Centre EIT+ (Poland) · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venous leg ulcers represent a clinical challenge and impair the quality of life of patients. This study examines impaired wound healing in venous leg ulcers at the molecular level. Protein expression patterns for biomarkers were analysed in venous leg ulcer wound fluids from 57 patients treated with a protease-modulating polyacrylate wound dressing for 12 weeks, and compared with exudates from 10 acute split-thickness wounds. Wound healing improved in the venous leg ulcer wounds: 61.4% of the 57 patients with venous leg ulcer achieved a relative wound area reduction of ≥ 40%, and 50.9% of the total 57 patients achieved a relative wound area reduction of ≥ 60%. Within the first 14 days, abundances of S100A8, S100A9, neutrophil elastase, matrix metalloproteinase-2, and fibronectin in venous leg ulcer exudates decreased significantly and remained stable, yet higher than in acute wounds. Interleukin-1β, tumour necrosis factor alpha, and matrix metalloproteinase-9 abundance ranges were similar in venous leg ulcers and acute wound fluids. Collagen (I) α1 abundance was higher in venous leg ulcer wound fluids and was not significantly regulated. Overall, significant biomarker changes occurred in the first 14 days before a clinically robust healing response in the venous leg ulcer cohort.

Indexed as

Leg UlcerVaricose UlcerHumansMatrix Metalloproteinase 2Peptide HydrolasesQuality of LifeSkin TransplantationMatrix Metalloproteinase 2Peptide Hydrolases

Identifiers

PMID36250733
PMCPMC9811302
OpenAlexW4306405222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.